Bitcoin, Equities React to Pfizer COVID-19 Vaccine Announcement

195 +

NVAX Stock Rises 7% in Pre-market as Novavax Starts Late-Stage Covid-19 Vaccine Trials in UK

Coinspeaker NVAX Stock Rises 7% in Pre-market as Novavax Starts Late-Stage Covid-19 Vaccine Trials in UKFollowing the news about the progress with COVID-19 vaccine trials, Novavax shares which closed 0.

168 +

Pharmaceutical Giant AstraZeneca Resumes Clinical Trials for COVID-19 Vaccine, AZN Stock Slightly Up

Coinspeaker Pharmaceutical Giant AstraZeneca Resumes Clinical Trials for COVID-19 Vaccine, AZN Stock Slightly UpIn partnership with U. K. 's Oxford University, AstraZeneca said that it will resume the phase three clinical trial for its COVID-19 vaccine contender AZD1222 since it got an approval from UK's Medicines Health Regulatory Authority.

193 +

MRNA Stock Up 16%, Moderna Confirms Its Covid-19 Vaccine Produces Neutralizing Antibodies

Coinspeaker MRNA Stock Up 16%, Moderna Confirms Its Covid-19 Vaccine Produces Neutralizing AntibodiesModerna (MRNA) stock price is rising. The rally is fueled by the company's announcement that its COVID-19 vaccine candidate produced neutralizing antibodies in all 45 participants.

203 +

JNJ Stock Up 0.67% as Johnson & Johnson Wants to Begin Late-Stage COVID-19 Vaccine Trial in September

Coinspeaker JNJ Stock Up 0. 67% as Johnson & Johnson Wants to Begin Late-Stage COVID-19 Vaccine Trial in SeptemberJohnson & Johnson (JNJ) stock price is rising as the company is moving forward with its vaccine trials.

139 +

BioNTech (BNTX) Stock Down 2% though Company Receives Approval for COVID-19 Vaccine Trials

Coinspeaker BioNTech (BNTX) Stock Down 2% though Company Receives Approval for COVID-19 Vaccine TrialsShanghai Fosun Pharmaceutical Industrial Development received the acceptance notice of clinical trial application for the COVID-19 vaccine candidate BNT162b1 created by BioNTech.

195 +

Wall Street pumps following vaccine news while Bitcoin struggles

Bitcoin fails to follow stock market rally as US biomedical firm Moderna, announces COVID-19... The post Wall Street pumps following vaccine news while Bitcoin struggles appeared first on Coin Journal.

277 +

MRNA Stock Price Up 5% as Moderna to Start Testing COVID-19 Vaccine on 30,000 People in July

Coinspeaker MRNA Stock Price Up 5% as Moderna to Start Testing COVID-19 Vaccine on 30,000 People in JulyModerna (MRNA) stock price is climbing to its ATH of $69 again. Currently, the shares are trading at around $63.

197 +

NVAX Stock Up Nearly 16% in Pre-market as Novavax Starts Coronavirus Vaccine Trials

Coinspeaker NVAX Stock Up Nearly 16% in Pre-market as Novavax Starts Coronavirus Vaccine TrialsNovavax (NVAX) has jumped by 16% in the pre-market. The company has announced human trials its COVID-19 vaccine.

241 +

Dow Futures Fade Because Vaccine Won’t Stop Virus Second Wave

Stocks rallied yesterday on Moderna's Covid-19 vaccine trial breakthrough, but health experts say it won't arrive in time to prevent a second wave of the virus. The post Dow Futures Fade Because Vaccine Won’t Stop Virus Second Wave appeared first on CCN.com

262 +

Smart Helmets Allow for Constant COVID-19 Infection Monitoring

To some people, it might appear as if the COVID-19 crisis is over and things will return to normal soon. For others, new technology will ensure that this pandemic remains under control until a proper vaccine has been developed.

118 +

Inovio (INO) Stock Rose 8% Yesterday, Up 5% Now as Hunt for COVID-19 Vaccine Goes On

Coinspeaker Inovio (INO) Stock Rose 8% Yesterday, Up 5% Now as Hunt for COVID-19 Vaccine Goes OnInovio (INO) stock was jumped 8% yesterday, is in the green now after the company released its fiscal Q1 earnings report, while it is working on a coronavirus vaccine.

296 +

Many Blockchain Projects Are Uniquely Suited to COVID-19 Research, Here’s How

In the wake of the recent pandemic, here’s how many different blockchain projects are stepping up to donate resources in the hopes of finding a vaccine.

215 +

Inovio (INO) Stock Rises 5.40% Today after 14.55% Loss on Friday

Coinspeaker Inovio (INO) Stock Rises 5. 40% Today after 14. 55% Loss on FridayWhile the company has had great gains as it works on a COVID-19 vaccine, Inovio (INO) stock fell last Friday, was down in the-premarket today but is up as trading began.

205 +

Diabolical Cryptocurrency and COVID-19 Vaccine: Oscar-Winning Director Has Insane Theory About Bill Gates

Russian director Nikita Mikhalkov joins the list of conspiracy theorists who spread falsehoods about Microsoft co-founder Bill Gates

126 +

MRNA Stock Up 2%, Moderna Signs Deal to Ramp Up 1B COVID-19 Vaccine Doses a Year

Coinspeaker MRNA Stock Up 2%, Moderna Signs Deal to Ramp Up 1B COVID-19 Vaccine Doses a YearModerna is moving forward with its coronavirus vaccine. The company announced a deal with Lonza Group AG to manufacture 1 billion coronavirus vaccine doses a year.

216 +

NVAX Stock Jumped 25% Yesterday, Down 15% Now as Novavax Works on COVID-19 Vaccine

Coinspeaker NVAX Stock Jumped 25% Yesterday, Down 15% Now as Novavax Works on COVID-19 VaccineNovavax (NVAX) stock climbed 25% yesterday, adding to its current 2020 gains, as the company makes progress on its COVID-19 vaccine candidate.

260 +

Foreign Hackers Targeting COVID-19 Vaccine R&D: Report

Hacker groups from several foreign countries have reportedly started targeting several companies conducting research into the coronavirus pandemic. Reuters recently reported that Tonya Ugoretz, a Deputy Assistant Director at the FBI, made the attempted hacks known at a panel conducted by international nonprofit think tank The Aspen Institute.

368 +

JNJ Stock Up 1%, Jim Cramer Says Johnson & Johnson Is Ahead of COVID-19 Vaccine Game

Coinspeaker JNJ Stock Up 1%, Jim Cramer Says Johnson & Johnson Is Ahead of COVID-19 Vaccine GameAccording to Jim Cramer, Johnson & Johnson COVID-19 vaccine candidate will help the public overcome fears of going out and spending money on entertainment.

135 +

Bill Gates Intends to Cash in on His COVID-19 Vaccine: ?Rich Dad, Poor Dad? Author

Entrepreneur and investment guru Robert Kiyosaki assumes that Bill Gates is making his COVID-19 vaccine to get an endless cash flow for the rest of his life

250 +

Bitcoin News Roundup for April 7, 2020

Crypto beats traditional markets while a COVID-19 vaccine enters human trials. It's CoinDesk's Markets Daily podcast.

138 +

JNJ, MRNA Stocks Down Around 1.5%, J&J and Moderna to Produce Possible COVID-19 Vaccine

Coinspeaker JNJ, MRNA Stocks Down Around 1. 5%, J&J and Moderna to Produce Possible COVID-19 VaccineThe U. S government has partnered Johnson & Johnson and Moderna to facilitate the production of the possible COVID-19 vaccine in large quantities.

210 +

5 Companies Lead the Race in Producing the First COVID-19 Vaccine

Coinspeaker 5 Companies Lead the Race in Producing the First COVID-19 VaccineFive pharmaceutical companies across the globe lead the race in producing the first approved COVID-19 vaccine.

204 +

When Coronavirus Vaccine Will Be Ready, Moderna and Many Others Working on It

Coinspeaker When Coronavirus Vaccine Will Be Ready, Moderna and Many Others Working on ItAs soon as a coronavirus vaccine is approved, it’s going to be needed in vast quantity, and many of the organizations in the Covid-19 vaccine race simply don’t have the necessary production capacity.

173 +

Cardano (ADA) Foundation engages in decentralized computing effort to fight COVID-19

The Cardano Foundation has called on the community to support a distributed computing project aimed at developing a vaccine for the coronavirus. A large number of its staff has decided to take part in the Folding@Home project, giving out their personal computers’ CPU to power scientific research.

176 +

Moderna (MRNA) Stock Down 10.48% after FDA Commissioner Comments on Vaccine Timeline

Coinspeaker Moderna (MRNA) Stock Down 10. 48% after FDA Commissioner Comments on Vaccine TimelineModerna (MRNA) stock tanked by 10. 48% on Thursday. The slide followed FDA Stephen Huhn's statement that the COVID-19 vaccine is at least a year away.

204 +

Moderna (MRNA) Stock Keeps Growing as First Batch of COVID-19 Vaccine Candidate Sent

Coinspeaker Moderna (MRNA) Stock Keeps Growing as First Batch of COVID-19 Vaccine Candidate SentModerna Inc (MRNA) stock has been skyrocketing since the company announced its mRNA COVID-19 vaccine has been successfully shipped to the National Institute of Allergy and Infectious Diseases.

205 +